Martinez M, Szwerinski N, Liang S, Chan S, de Bruin M, Stults C
Inquiry. 2025; 62:469580251314747.
PMID: 39851053
PMC: 11758521.
DOI: 10.1177/00469580251314747.
Batool Z, Kamal M, Shen B
Breast Cancer. 2024; 32(2):258-277.
PMID: 39688807
DOI: 10.1007/s12282-024-01660-9.
Bednar E, Wilke R, Jorgensen K, Walsh Jr M, Nutt S, Lu K
J Community Genet. 2024; 15(6):681-686.
PMID: 39397225
PMC: 11645378.
DOI: 10.1007/s12687-024-00744-5.
Kaphingst K, Kohlmann W, Lorenz Chambers R, Bather J, Goodman M, Bradshaw R
JAMA Netw Open. 2024; 7(9):e2432143.
PMID: 39250153
PMC: 11385050.
DOI: 10.1001/jamanetworkopen.2024.32143.
Rezoug Z, Totten S, Szlachtycz D, Atayan A, Mohler K, Albert S
JAMA Netw Open. 2024; 7(9):e2431427.
PMID: 39226054
PMC: 11372499.
DOI: 10.1001/jamanetworkopen.2024.31427.
Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
Gilmore M, Leo M, Amendola L, Goddard K, Hunter J, Joseph G
Transl Behav Med. 2024; 14(7):377-385.
PMID: 38190737
PMC: 11208290.
DOI: 10.1093/tbm/ibad084.
Patient experiences in receiving telegenetics care for inherited cardiovascular diseases.
Temares D, Liang L, Bergner A, Reilly M, Kalia I
J Community Genet. 2023; 15(2):119-127.
PMID: 38095830
PMC: 11031528.
DOI: 10.1007/s12687-023-00693-5.
Evaluation of Group Genetic Counseling Sessions via a Metaverse-based Application.
Yoo B, Kim A, Moon H, So M, Jeong T, Lee K
Ann Lab Med. 2023; 44(1):82-91.
PMID: 37665289
PMC: 10485865.
DOI: 10.3343/alm.2024.44.1.82.
Ethical, legal, and social implications (ELSI) and challenges in the design of a randomized controlled trial to test the online return of cancer genetic research results to U.S. Black women.
Wang C, Bertrand K, Trevino-Talbot M, Flynn M, Ruderman M, Cabral H
Contemp Clin Trials. 2023; 132:107309.
PMID: 37516165
PMC: 10544717.
DOI: 10.1016/j.cct.2023.107309.
Privacy and utility of genetic testing in families with hereditary cancer syndromes living in three countries: the international cascade genetic screening experience.
Barnoy S, Dagan E, Kim S, Caiata-Zufferey M, Katapodi M
Front Genet. 2023; 14:1109431.
PMID: 37229185
PMC: 10203600.
DOI: 10.3389/fgene.2023.1109431.
Rapid Implementation of Telegenetic Counseling in the COVID-19 and Swedish Healthcare Context: A Feasibility Study.
Pestoff R, Johansson P, Danielsson H, Neher M, Gunnarsson C
Front Health Serv. 2023; 2:848512.
PMID: 36925809
PMC: 10012799.
DOI: 10.3389/frhs.2022.848512.
Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol.
Espinoza Moya M, Guertin J, Dorval M, Lapointe J, Bouchard K, Nabi H
BMJ Open. 2022; 12(12):e066802.
PMID: 36523215
PMC: 9748975.
DOI: 10.1136/bmjopen-2022-066802.
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: , , and .
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S
J Med Genet. 2022; 60(5):417-429.
PMID: 36411032
PMC: 10176381.
DOI: 10.1136/jmg-2022-108898.
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result.
Blondeaux E, Lambertini M, Buzzatti G, Bruzzone C, Baraga M, Pisani R
J Genet Couns. 2022; 32(1):140-152.
PMID: 36036895
PMC: 10087002.
DOI: 10.1002/jgc4.1630.
Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants.
Allen C, Lenert L, Hunt K, Jackson A, Levin E, Clinton C
J Pers Med. 2022; 12(8).
PMID: 36013178
PMC: 9410232.
DOI: 10.3390/jpm12081228.
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO).
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y
J Gynecol Oncol. 2022; 33(5):e61.
PMID: 35882604
PMC: 9428299.
DOI: 10.3802/jgo.2022.33.e61.
Remote vs in-person BRCA1/2 non-carriers test disclosure: patients' choice during Covid-19 pandemic restriction.
Costanzo S, De Summa S, Maurmo L, Digennaro M, Patruno M, Angelo Paradiso
Fam Cancer. 2022; 22(1):43-48.
PMID: 35867288
PMC: 9304797.
DOI: 10.1007/s10689-022-00307-y.
A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations.
Allen C, Judge D, Levin E, Sterba K, Hunt K, Ramos P
Implement Sci Commun. 2022; 3(1):48.
PMID: 35484601
PMC: 9052691.
DOI: 10.1186/s43058-022-00286-2.
The use of telemedicine in cardiogenetics clinical practice during the COVID-19 pandemic.
Liang L, Kalia I, Latif F, Waase M, Shimada Y, Sayer G
Mol Genet Genomic Med. 2022; 10(6):e1946.
PMID: 35388985
PMC: 9184656.
DOI: 10.1002/mgg3.1946.
Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes.
Binion S, Sorgen L, Peshkin B, Valdimarsdottir H, Isaacs C, Nusbaum R
J Telemed Telecare. 2021; 30(2):334-343.
PMID: 34779303
PMC: 9902210.
DOI: 10.1177/1357633X211052220.